$0.03
$0.00 (0.00%)
End-of-day quote: 05/17/2024
NasdaqCM:DMK
DMK Pharmaceuticals Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| TEVA | Teva Pharmaceutical Industries | NYSE | Outperform | $16.29 | $11.59 | 0.00% | 9 | $18.45B |
| HIK | Hikma Pharmaceuticals PLC | LSE | Outperform | £19.78 | £28.11 | 0.00% | 9 | £4.42B |
| AMPH | Amphastar Pharmaceuticals | NasdaqGS | Outperform | $43.48 | $69.00 | 0.00% | 0 | $2.09B |
| SUPN | Supernus Pharmaceuticals | NasdaqGM | Outperform | $29.10 | $41.00 | 0.00% | 0 | $1.72B |
| ANIP | ANI Pharmaceuticals | NasdaqGM | Buy | $61.43 | $69.75 | 0.00% | 1 | $1.38B |
| IRWD | Ironwood Pharmaceuticals | NasdaqGS | Buy | $6.48 | $17.83 | 0.00% | 2 | $1.29B |
| COLL | Collegium Pharmaceutical | NasdaqGS | Outperform | $32.47 | $37.75 | 0.00% | 1 | $1.24B |
| PCRX | Pacira BioSciences | NasdaqGS | Outperform | $30.82 | $47.90 | 0.00% | 6 | $1.23B |
| BDSI | BioDelivery Sciences Internati... | NasdaqGS | - | $5.59 | $10.00 | 0.00% | 0 | $577.05M |
| AQST | Aquestive Therapeutics | NasdaqGM | Buy | $3.11 | $6.33 | 0.00% | 0 | $307.71M |
| EBS | Emergent BioSolutions | NYSE | Outperform | $5.55 | $5.00 | 0.00% | 0 | $229.00M |
| ZVRA | Zevra Therapeutics | NasdaqGS | Buy | $4.73 | $19.50 | 0.00% | 1 | $204.66M |
| DCTH | Delcath Systems | NasdaqCM | Buy | $7.57 | $19.25 | 0.00% | 1 | $196.44M |
| ASRT | Assertio Holdings | NasdaqCM | Buy | $1.07 | $3.50 | 0.00% | 2 | $100.36M |
| DRRX | DURECT | NasdaqCM | Outperform | $0.93 | $6.75 | 0.00% | 2 | $33.21M |
| CPIX | Cumberland Pharmaceuticals | NasdaqGS | - | $2.03 | $8.50 | 0.00% | 0 | $24.38M |
| ACRX | AcelRx Pharmaceuticals | NasdaqGM | Outperform | $1.08 | $4.63 | 0.00% | 0 | $17.33M |
| ACOR | Acorda Therapeutics | NasdaqGS | - | $0.43 | $200.00 | 0.00% | 1 | $0.53M |
